HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lipodystrophy

A collection of heterogenous conditions resulting from defective LIPID METABOLISM and characterized by ADIPOSE TISSUE atrophy. Often there is redistribution of body fat resulting in peripheral fat wasting and central adiposity. They include generalized, localized, congenital, and acquired lipodystrophy.
Also Known As:
Lipodystrophies
Networked: 2297 relevant articles (105 outcomes, 232 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Insulin Resistance
2. Dyslipidemias (Dyslipidemia)
3. HIV Infections (HIV Infection)
4. Hyperglycemia
5. Acquired Immunodeficiency Syndrome (AIDS)

Experts

1. Domingo, Pere: 42 articles (01/2022 - 08/2002)
2. Brown, Rebecca J: 37 articles (06/2022 - 09/2012)
3. Capeau, Jacqueline: 37 articles (04/2022 - 03/2002)
4. Gorden, Phillip: 36 articles (01/2021 - 02/2002)
5. Vigouroux, Corinne: 34 articles (11/2022 - 03/2002)
6. Garg, Abhimanyu: 30 articles (01/2022 - 02/2002)
7. Villarroya, Francesc: 23 articles (01/2022 - 02/2005)
8. Mantzoros, Christos S: 22 articles (01/2022 - 02/2003)
9. Cochran, Elaine: 21 articles (06/2022 - 04/2004)
10. Guaraldi, Giovanni: 20 articles (01/2017 - 03/2003)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Lipodystrophy:
1. LeptinIBA
2. metreleptinIBA
3. Insulin (Novolin)FDA Link
4. Glucose (Dextrose)FDA LinkGeneric
5. Triglycerides (Triacylglycerol)IBA
6. LipidsIBA
7. tesamorelinFDA Link
8. ThiazolidinedionesIBA
9. Ritonavir (Norvir)FDA Link
10. Mitochondrial DNA (mtDNA)IBA

Therapies and Procedures

1. Therapeutics
2. Highly Active Antiretroviral Therapy (HAART)
3. Lipectomy (Liposuction)
4. Glycemic Control
5. Operative Surgical Procedures